Literature DB >> 3660304

Peripheral blood eosinophil counts and bronchial responsiveness.

K J Taylor1, A R Luksza.   

Abstract

Bronchial responsiveness (histamine PC20) and peripheral blood eosinophil counts were measured in 23 asthmatic subjects, of whom 14 were atopic and nine non-atopic. In the group as a whole there was an inverse correlation between baseline eosinophil count and histamine PC20 (r = -0.71; p less than 0.001). For atopic subjects a relationship between eosinophil count and histamine PC20 was observed (r = -0.74; p less than 0.01), but there was no correlation between eosinophil count and baseline FEV1 or baseline FEV1 and histamine PC20. For the non-atopic subjects a similar relationship between eosinophil count and histamine PC20 was seen (r = -0.68; p less than 0.05) and a less significant inverse correlation between baseline eosinophil count and baseline FEV1 (r = -0.65; p less than 0.05). These results show a relationship between eosinophil count and non-specific bronchial responsiveness in both atopic and non-atopic asthma.

Entities:  

Mesh:

Year:  1987        PMID: 3660304      PMCID: PMC460778          DOI: 10.1136/thx.42.6.452

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  18 in total

1.  Bronchial reactivity to inhaled histamine: a method and clinical survey.

Authors:  D W Cockcroft; D N Killian; J J Mellon; F E Hargreave
Journal:  Clin Allergy       Date:  1977-05

2.  The effect of corticosteroids on methacholine inhalation in symptomatic bronchial asthma.

Authors:  J A Arkins; D P Schleuter; J N Fink
Journal:  J Allergy       Date:  1968-04

3.  Effect of propranolol on the isoproterenol, responses of cortisol, isoproterenol, and aminophylline.

Authors:  J L Ohman; M Lawrence; F C Lowell
Journal:  J Allergy Clin Immunol       Date:  1972-09       Impact factor: 10.793

4.  Diurnal variation in the number of circulating eosinophil leucocytes in normal controls and asthmatics.

Authors:  R Dahl
Journal:  Acta Allergol       Date:  1977-10

5.  Cytotoxic properties of the eosinophil major basic protein.

Authors:  G J Gleich; E Frigas; D A Loegering; D L Wassom; D Steinmuller
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

6.  The use of corticosteroids in the treatment of acute asthma.

Authors:  J V Collins; T J Clark; D Brown; J Townsend
Journal:  Q J Med       Date:  1975-04

7.  Total eosinophil counts in the management of bronchial asthma.

Authors:  B R Horn; E D Robin; J Theodore; A Van Kessel
Journal:  N Engl J Med       Date:  1975-05-29       Impact factor: 91.245

8.  Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection.

Authors:  D W Empey; L A Laitinen; L Jacobs; W M Gold; J A Nadel
Journal:  Am Rev Respir Dis       Date:  1976-02

9.  Bronchoalveolar lavage in asthma: the effect of disodium cromoglycate (cromolyn) on leukocyte counts, immunoglobulins, and complement.

Authors:  P Diaz; F R Galleguillos; M C Gonzalez; C F Pantin; A B Kay
Journal:  J Allergy Clin Immunol       Date:  1984-07       Impact factor: 10.793

10.  Bronchial hyperirritability in healthy subjects after exposure to ozone.

Authors:  J A Golden; J A Nadel; H A Boushey
Journal:  Am Rev Respir Dis       Date:  1978-08
View more
  19 in total

Review 1.  The role of eosinophils in asthma.

Authors:  C Kroegel
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 2.  Update on reslizumab for eosinophilic asthma.

Authors:  Juan Carlos Cardet; Elliot Israel
Journal:  Expert Opin Biol Ther       Date:  2015       Impact factor: 4.388

3.  Role of airway eosinophilia and eosinophil activation in Sephadex-induced inflammation.

Authors:  Karim Maghni; François Nantel; Chantal Lanoue; Solange Cloutier; Jean-Paul Cristol; Alain Cadieux; Pierre Sirois
Journal:  Inflammation       Date:  2004-08       Impact factor: 4.092

4.  Quantification of theophylline-induced eosinopenia and hypokalaemia in healthy volunteers.

Authors:  M C Braat; R E Jonkers; E H Bel; C J Van Boxtel
Journal:  Clin Pharmacokinet       Date:  1992-03       Impact factor: 6.447

Review 5.  The role of platelet activating factor in allergic respiratory disease.

Authors:  C P Page
Journal:  Br J Clin Pharmacol       Date:  1990       Impact factor: 4.335

Review 6.  Asthma outcomes: biomarkers.

Authors:  Stanley J Szefler; Sally Wenzel; Robert Brown; Serpil C Erzurum; John V Fahy; Robert G Hamilton; John F Hunt; Hirohito Kita; Andrew H Liu; Reynold A Panettieri; Robert P Schleimer; Michael Minnicozzi
Journal:  J Allergy Clin Immunol       Date:  2012-03       Impact factor: 10.793

7.  A novel thromboxane synthetase inhibitor, DP-1904, inhibits human blood eosinophil degranulation.

Authors:  D K Agrawal; M Takami; S Ono
Journal:  Inflammation       Date:  1997-02       Impact factor: 4.092

Review 8.  Predictive Biomarkers for Asthma Therapy.

Authors:  Sarah K Medrek; Amit D Parulekar; Nicola A Hanania
Journal:  Curr Allergy Asthma Rep       Date:  2017-09-19       Impact factor: 4.806

9.  Kinetics of eosinophilia and eosinophil activation in the development of non-allergic bronchial hyperresponsiveness in guinea pigs injected with Sephadex beads.

Authors:  K Maghni; M J Simard; D Arseneault; P Sirois
Journal:  Inflammation       Date:  1996-10       Impact factor: 4.092

10.  Cyclic AMP-elevating agents prolong or inhibit eosinophil survival depending on prior exposure to GM-CSF.

Authors:  M P Hallsworth; M A Giembycz; P J Barnes; T H Lee
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.